About the Emerging Technologies & Future Directions in Cancer Research Session
Rapid advances in experimental technologies are creating new opportunities to understand cancer biology and develop innovative therapeutic strategies. This session provides a platform for forward-looking research involving novel models, advanced molecular technologies, gene editing, spatial and single-cell approaches, and emerging therapeutic platforms.
Abstract Scope and Participation
Submissions may include organoids, advanced tumor models, CRISPR and gene editing, single-cell technologies, spatial biology, nanotechnology, radiotheranostics, targeted radiopharmaceuticals, novel research platforms, and emerging cancer therapies. Researchers from academic, clinical, engineering, and industry backgrounds are invited.
Topics Covered in Emerging Technologies & Future Directions in Cancer Research
Topic 01
Cancer Organoids
Topic 02
CRISPR & Gene Editing
Topic 03
Single-Cell Technologies
Topic 04
Spatial Biology
Topic 05
Radiotheranostics
Topic 06
Emerging Therapies
Featured Speakers — Emerging Technologies & Future Directions in Cancer Research 2027
Recent Research Presented at Emerging Technologies & Future Directions in Cancer Research Sessions
Nanomedicine in over 45,000 patients and no cancer
Nanomedicine is the use of nanomaterials to improve disease prevention, detection, and treatment which has resulted in hundreds of US FDA approved medical products. While nanomedicine has been around…
A prospective study of tislelizumab combined with radiotherapy in unresectable or recurrent advanced hepatocellular carcinoma: Efficacy and immunological safety analysis
Background: Radiotherapy (RT) can induce immunogenic cell death and enhance tumor antigen release and presentation, thereby augmenting the host anti-tumor immune response. The combination of PD-1…
Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
In this keynote talk, the use of the Hill model to assess the Benchmark dose (BMD), the lethal dose 50 (LD50), the cooperativity (E), and the dissociation constant (K) while analyzing cell viability…
Related Scientific Sessions at CIOC 2027
Why Attend the Emerging Technologies & Future Directions in Cancer Research Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Emerging Technologies & Future Directions in Cancer Research work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Emerging Technologies & Future Directions in Cancer Research research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Emerging Technologies & Future Directions in Cancer Research track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Emerging Technologies & Future Directions in Cancer Research Conference 2027 — FAQs
What is the Emerging Technologies & Future Directions in Cancer Research track at CIOC 2027?
The Emerging Technologies & Future Directions in Cancer Research track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Emerging Technologies & Future Directions in Cancer Research. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Emerging Technologies & Future Directions in Cancer Research sessions?
Cancer researchers and clinicians, educators and students with an interest in Emerging Technologies & Future Directions in Cancer Research are all welcome — whether presenting or attending.
Can I present my research in the Emerging Technologies & Future Directions in Cancer Research track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Emerging Technologies & Future Directions in Cancer Research sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Emerging Technologies & Future Directions in Cancer Research track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.